Here we further demonstrated that the addition of circulating TSP2 levels to conventional clinical variables also significantly improved the prediction of HHF over years in type 2 diabetes, potentially allowing early HF risk stratification and treatment prioritization. Here, THBS2 is linked to type 2 diabetes mellitus.